Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Stocks That Could Benefit From a GOP-Led Congress

November 8, 2014 10:06 am | by Ken Sweet - AP Business Writer - Associated Press | News | Comments

Lower taxes for medical device makers. Lighter regulations for coal. If the new Republican-led Congress manages to push through these policy changes it could lift stocks in the health and energy industries, market strategists say.    

TOPICS:

Salix Reports Third Quarter Loss, CFO Resigns

November 6, 2014 6:07 pm | by The Associated Press | News | Comments

Salix Pharmaceuticals posted lower-than-expected quarterly results and announced the abrupt resignation of its chief financial officer, and shares of the specialty drugmaker plunged in extended trading Thursday.       

TOPICS:

Interchangeable, Maintenance-Free Cartridges Replace Multi Stage Pumps

November 6, 2014 2:46 pm | Product Releases | Comments

The RTM Series™ of maintenance-free venturi cartridges are ideally suited for the packaging industry, replacing failed or clogged multi-stage pumps to maximize productivity and minimize downtime.

Advertisement

Cleanroom Energy Efficiency Opportunities

November 6, 2014 2:37 pm | by Al Fosco, Frigel North America | Articles | Comments

Like so many industries, pharmaceutical processing is increasingly focused on improving the operational energy efficiency. One challenge that often stands in the way: cleanrooms. In these facilities, energy efficiency understandably takes a back seat to the mission of clean production. As a result, due to FDA-required filtration, high-performance processing machines and other factors, cleanrooms are energy intensive.

TOPICS:

Nurse Who Caught Ebola Says More Training Needed

November 6, 2014 2:25 pm | News | Comments

A nurse who was infected with Ebola after treating a sick patient said she didn't have enough training beforehand on how to protect herself. Vinson was one of the more than 70 medical personnel who were involved in the care of Thomas Eric Duncan at Texas Health Presbyterian Hospital Dallas.

TOPICS:

Eurofins Acquires SF Analytical Labs

November 6, 2014 2:17 pm | News | Comments

Eurofins Scientific has announced the pending acquisition of SF Analytical (SFA) Laboratories. The transaction will close at the end of November. The acquisition strengthens Eurofins' growing presence in the US, as well as expands the current base of operations in the Midwestern United States.

TOPICS:

GlobalData: Israel’s Scientific Ethos to Drive Pharma Industry Value Beyond $2.3B by 2020

November 6, 2014 1:39 pm | News | Comments

Israel’s pharmaceutical market value will increase from approximately $1.9 billion in 2013 to $2.34 billion by 2020, driven by medical technology advances, high research and development (R&D) expenditure and a robust economy, according to research and consulting firm GlobalData.

TOPICS:

Ex-Pharma Exec Guilty of Manslaughter in Autistic Son's Death

November 6, 2014 1:33 pm | by JENNIFER PELTZ, Associated Press | News | Comments

A health care millionaire who fatally drugged her developmentally disabled son was convicted of manslaughter Wednesday in what her defense portrayed as a mercy killing by a mother trying to escape a labyrinth of fear and despair.    

TOPICS:
Advertisement

Training Key in Fight Against Ebola

November 6, 2014 1:26 pm | Videos | Comments

Volunteers undergo training before heading to West Africa to fight Ebola.                              

TOPICS:

Study Shows Popular Cosmetic Procedures Can Be Safe

November 6, 2014 1:21 pm | Videos | Comments

Study finds Botox, laser and other nonsurgical treatments showed negative side effects to less than 1 percent of users.                      

TOPICS:

FDA Approves Ipsen's New Delivery Device for Somatuline® Depot® (lanreotide) Injection

November 6, 2014 11:44 am | News | Comments

Ipsen Biopharmaceuticals announced that the FDA has approved a new device to deliver Somatuline® Depot® (lanreotide). The device has an enhanced, prefilled, low-volume syringe that supports full-dose delivery with no reconstitution requirements.

TOPICS:

Amid Ebola Disaster, WHO Picks New Africa Chief

November 6, 2014 11:02 am | by VIRGILE AHISSOU, Associated Press; MARIA CHENG, Associated Press | News | Comments

With nearly 5,000 dead of Ebola in West Africa, the World Health Organization elected a new director Wednesday of its Africa office, which has been accused of bungling the response to the outbreak in its early stages.      

TOPICS:

China Factory Whirs Overtime to Make Ebola Suits

November 6, 2014 10:56 am | by ZHANG WEIQUN, Associated Press | News | Comments

Far from the Ebola hot zone, the sewing and gluing machines at a factory in China have been whirring more than usual to produce crucial yellow suits that protect the front-line medics more than 11,000 kilometers (7,000 miles) away in West Africa.

TOPICS:

AstraZeneca to Divest Myalept to Aegerion

November 6, 2014 10:44 am | News | Comments

AstraZeneca has entered into a definitive agreement with Aegerion Pharmaceuticals, Inc. to divest Myalept™ (metreleptin for injection), an orphan product that is indicated to treat complications of leptin deficiency in patients with generalized lipodystrophy.

TOPICS:

Ebola Countries to Get $450M in Financing

November 6, 2014 8:58 am | by EDITH M. LEDERER, Associated Press | News | Comments

A new private sector initiative announced Wednesday will provide at least $450 million in commercial financing to the three West African countries hardest hit by Ebola to promote trade, investment and employment.       

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading